share_log

Hempacco (NASDAQ:HPCO) Vs. 22nd Century Group (NASDAQ:XXII) Head to Head Review

Hempacco (NASDAQ:HPCO) Vs. 22nd Century Group (NASDAQ:XXII) Head to Head Review

漢普科(納斯達克:HPCO)訴22世紀集團(納斯達克:XXII)正面評論
Defense World ·  2022/09/30 13:31

Hempacco (NASDAQ:HPCO – Get Rating) and 22nd Century Group (NASDAQ:XXII – Get Rating) are both small-cap consumer discretionary companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, dividends, valuation and earnings.

亨普科(納斯達克:HPCO-GET評級)和22世紀集團(納斯達克:XXII-GET評級)都是小型非必需消費品公司,但哪隻股票更好?我們將根據這兩家公司的風險、盈利能力、分析師建議、機構持股、股息、估值和收益的強弱對它們進行比較。

Earnings & Valuation

收益與估值

This table compares Hempacco and 22nd Century Group's gross revenue, earnings per share and valuation.

此表比較了漢普科和22世紀集團的毛收入、每股收益和估值。

Get
到達
Hempacco
漢普科
alerts:
警報:
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Hempacco N/A N/A N/A N/A N/A
22nd Century Group $30.95 million 6.54 -$32.61 million ($0.26) -3.63
總收入 價格/銷售額比 淨收入 每股收益 市盈率
漢普科 不適用 不適用 不適用 不適用 不適用
22世紀集團 3095萬美元 6.54 -3,261萬元 ($0.26) -3.63

Hempacco has higher earnings, but lower revenue than 22nd Century Group.

漢普科的收益高於22世紀集團,但營收低於22世紀集團。

Analyst Recommendations

分析師建議

This is a breakdown of recent recommendations for Hempacco and 22nd Century Group, as reported by MarketBeat.
這是MarketBeat報道的對漢普科和22世紀集團最近建議的細目。
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hempacco 0 0 0 0 N/A
22nd Century Group 0 0 4 0 3.00
銷售評級 保持評級 購買評級 強勁的買入評級 評級分數
漢普科 0 0 0 0 不適用
22世紀集團 0 0 4 0 3.00

22nd Century Group has a consensus target price of $6.13, suggesting a potential upside of 549.66%. Given 22nd Century Group's higher possible upside, analysts plainly believe 22nd Century Group is more favorable than Hempacco.

22世紀集團的普遍目標價為6.13美元,暗示潛在上漲549.66%。考慮到22世紀集團更有可能的上行空間,分析師們顯然認為22世紀集團比漢普科更有利。

Profitability

盈利能力

This table compares Hempacco and 22nd Century Group's net margins, return on equity and return on assets.

此表比較了漢普科和22世紀集團的淨利潤率、股本回報率和資產回報率。

Net Margins Return on Equity Return on Assets
Hempacco N/A N/A N/A
22nd Century Group -111.52% -51.39% -44.63%
淨利潤率 股本回報率 資產回報率
漢普科 不適用 不適用 不適用
22世紀集團 -111.52% -51.39% -44.63%

Institutional & Insider Ownership

機構與內部人持股

19.8% of 22nd Century Group shares are held by institutional investors. 2.4% of 22nd Century Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

22世紀集團19.8%的股份由機構投資者持有。22世紀集團2.4%的股份由內部人士持有。強大的機構持股表明,對衝基金、大型基金管理公司和捐贈基金相信,一隻股票有望實現長期增長。

Summary

摘要

22nd Century Group beats Hempacco on 5 of the 8 factors compared between the two stocks.

22世紀集團在兩隻股票比較的8個因素中有5個擊敗了漢普科。

About Hempacco

關於漢普科

(Get Rating)

(獲取評級)

Hempacco Co., Inc. manufactures and sells smokable hemp and herb products in California. It offers The Real Stuff hemp smokables. The company was formerly known as The Hempacco Co., Inc. and changed its name to Hempacco Co., Inc. in May 2021. The company was incorporated in 2019 and is headquartered in San Diego, California. Hempacco Co., Inc. operates as a subsidiary of Green Globe International, Inc.

漢普科公司在加利福尼亞州製造和銷售可煙燻大麻和草藥產品。它提供真正的大麻煙薰製品。該公司前身為漢普科公司,並於2021年5月更名為漢普科公司。該公司成立於2019年,總部位於加利福尼亞州聖地亞哥。漢普科公司是綠色環球國際公司的子公司。

About 22nd Century Group

關於22世紀集團

(Get Rating)

(獲取評級)

22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.

22世紀集團公司是一家農業生物技術公司,專注於減少煙草危害,減少尼古丁煙草,並通過植物科學為生命科學和消費品行業提高健康和健康。該公司開發尼古丁含量極低的煙草和捲煙產品,並以VLN King和VLN薄荷醇王的名稱命名;以及用於獨立臨牀研究的光譜研究香煙。該公司與Keygene N.V.合作開發大麻/大麻植物,用於特殊的大麻素特徵和其他用於醫療、治療和農業以及其他應用的優良農藝性狀。22世紀集團成立於1998年,總部設在紐約布法羅。

Receive News & Ratings for Hempacco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hempacco and related companies with MarketBeat.com's FREE daily email newsletter.

接受《漢普科日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對漢普科和相關公司的最新新聞和分析師評級的每日簡要摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論